. Author manuscript; available in PMC: 2020 Dec 1.

Published in final edited form as: J Cancer Surviv. 2019 Nov 19;13(6):943–955. doi: 10.1007/s11764-019-00811-8

Table 2.

Risk-of-bias analysis using successive inclusion criteria

Criteria	Studies (Effects)	Estimate [SE]	95% CI	$\hat{τ}$	I²

All studies	28 (76)	0.35 [0.09]	[0.16, 0.54]	0.40	78%
+ Low ROB outcome reporting	18 (49)	0.32 [0.09]	[0.14, 0.50]	0.25	59%
+ Low ROB sequence generation	11 (28)	0.27 [0.13]	[−0.01, 0.56]	0.33	65%
+ Low ROB allocation concealment	5 (15)	0.10 [0.07]	[−0.12, 0.31]	0.00	0%
+ Overall attrition < 10%	2 (3)	0.16 [0.03]	[−0.19, 0.50]	0.00	0%

Note: ROB = risk-of-bias.